Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $3.01, $0.23 better than the analyst estimate of $2.78. Revenue for the quarter came in at $533.3 million versus the consensus estimate of $543.08 million.

GUIDANCE:

Medpace Holdings sees FY2024 EPS of $11.71-$12.09, versus the consensus of $11.79. Medpace Holdings sees FY2024 revenue of $2.09-2.13 billion, versus the consensus of $2.14 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.